0001567619-21-016965.txt : 20210910 0001567619-21-016965.hdr.sgml : 20210910 20210910161918 ACCESSION NUMBER: 0001567619-21-016965 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210908 FILED AS OF DATE: 20210910 DATE AS OF CHANGE: 20210910 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jones Erin CENTRAL INDEX KEY: 0001754278 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38663 FILM NUMBER: 211247279 MAIL ADDRESS: STREET 1: C/O GRITSTONE ONCOLOGY, INC. STREET 2: 5858 HORTON STREET, SUITE 210 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gritstone bio, Inc. CENTRAL INDEX KEY: 0001656634 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5959 HORTON STREET, SUITE 300 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 871-6100 MAIL ADDRESS: STREET 1: 5959 HORTON STREET, SUITE 300 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: Gritstone Oncology, Inc. DATE OF NAME CHANGE: 20151023 4 1 doc1.xml FORM 4 X0306 4 2021-09-08 0 0001656634 Gritstone bio, Inc. GRTS 0001754278 Jones Erin C/O GRITSTONE ONCOLOGY, INC. 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608 0 1 0 0 See Remarks Common Stock 2021-09-08 4 M 0 2000 0.345 A 22000 D Common Stock 2021-09-08 4 S 0 2000 11.3738 D 20000 D Stock Option (Right to Buy) 0.345 2021-09-08 4 M 0 2000 0 D 2026-05-17 Common Stock 2000 35971 D The transaction was made pursuant to a 10b5-1 plan in effect at the time of the transaction. Fully exercisable. Executive Vice President, Global Regulatory Affairs and Quality /s/ Rahsaan Thompson, Attorney-in-Fact for Erin Jones 2021-09-10